Contact

Please use this form to send email to PR contact of this press release:
Positive Phase 1 Results in Covid-19 Patients for Histogen, Inc. (NASDAQ: HSTO) Regenerative Medicine as well

TO:
HSTO
Histogen Inc.
+1 858-526-3100

FROM:
Your Name:
Your Email:	Please check your email address!
Subject:
Message:
Confirmation code:	Please, do not fill this field.
Confirmation version code:	Please, do not change this field.
Javascript data:	Please, do not fill if your javascript is turned off.
Please type in the code you see in the image. Or click Send Email to generate another image instead.
	SEND EMAIL